Post mastectomy radiotherapy in one to three lymph node positive breast cancer

References

• Lee MC, Jagsi R. Postmastectomy radiation therapy: Indications and controversies. Surg Clin North Am 2007;87:511–26.
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: An overview of randomised trials. Lancet 2005;365:1687–717.
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: An overview of randomized trials. N Engl J Med 1995;333:1444–55.
   PubMed Web of Science ®Google Scholar
• Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949–55.
   PubMed Web of Science ®Google Scholar
• Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, . Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641–8.
   PubMed Web of Science ®Google Scholar
• Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, . Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956–62.
   PubMed Web of Science ®Google Scholar
• Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, . Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trials. Lancet 2005;366:2087–106.
   PubMed Web of Science ®Google Scholar
• Tylor ME, Bruce GH, Rachel R, Douglas WA, Francine EH, Eric A, . Postmastegtomy radiotherapy. Americam College of Radiology. ACR Appropriateness criteria. Radiology 2000;215:1153–70.
   PubMedGoogle Scholar
• Troung PT, Olivotto IA, Whelan TJ, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post mastectomy radiotherapy. CMAJ 2004;170:1263–73.
   PubMed Web of Science ®Google Scholar
• Harris JR, Halpin-Murphy P, McNeese M, Mendenhall N P, Morrow M, Robert NJ, . Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 1999;1999:5:989–90.
   Google Scholar
• Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn H-J, . Thresholds for therapies: Highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer. Ann Oncol 2009;20: 1319–29.
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Wood WC, Gelber RDA, Coates S, Thürlimann B, Senn H-J, . Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007;18:1133–44.
   PubMed Web of Science ®Google Scholar
• Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiotherapy improve survival in breast cancer? A metaanalysis. J Clin Oncol 2000;18:1220–9.
   PubMed Web of Science ®Google Scholar
• Recht A, Gray R, Davidson NE, Fowble BL, Solin LJ, Cummings FJ, . Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999;17:1689–700.
   PubMed Web of Science ®Google Scholar
• Taghian A, Jeong JH, Mamounas E, Anderson S, Bryant J, Deutsch M, . Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without Tamoxifen and without radiotherapy: Results from the five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2004;22:4247–54.
   PubMed Web of Science ®Google Scholar
• Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, . Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 2000;18: 2817–27.
   PubMed Web of Science ®Google Scholar
• Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 2007;82:247–53.
   PubMed Web of Science ®Google Scholar
• Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Locoregional radiation therapy in patients with high risk breast cancer receiving adjuvant chemotherapy: 20-year results of British Columbia randomised trial. J Nat Cancer Inst 2005;97:116–26.
   PubMedGoogle Scholar
• Poortmans P. A bright future for radiotherapy in breast cancer. Rad Oncol 2007;82:243–6.
   Google Scholar
• Patt DA, Goodwin JS, Kuo YF, Freeman JL, Zhang DD, Buchholz TA, . Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 2005;23:7475–82.
   PubMed Web of Science ®Google Scholar
• Munshi A, Talapatra K, Dutta D. Breast cancer radiotherapy and cardiac risk. Oncol Rev 2010;4:137–46.
   Google Scholar
• Shang YP, Chen CM, Liu MC, Jian JM, Horng CF, Liu MJ, . Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status. Int J Radiat Oncol Biol Phys 2010;77:516–22.
   PubMed Web of Science ®Google Scholar
• Truong PT, Berthelet E, Lee J, Kader HA, Olivotto A. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 2005;103:2006–14.
   PubMed Web of Science ®Google Scholar
• Truong PT, Woodward WA, Thames HD, Ragaz J, Olivotto IA, Buchholz TA. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: An analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 2007;68:59–65.
   PubMed Web of Science ®Google Scholar
• Kyndi M, Overgaard M, Nielsen HM, Sorensen FB, Knudsen H, Overgaard J, . High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c. Radiother Oncol 2009;90:74–9.
   PubMed Web of Science ®Google Scholar
• Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J, . Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group. J Clin Oncol 2008;26:1419–26.
   PubMed Web of Science ®Google Scholar
• Russell NS, Kunkler IH, van Tienhoven G, Canney PA, Thomas J, Bartlett J, . Postmastectomy radiotherapy: Will the selective use of postmastectomy radiotherapy study end the debate? J Clin Oncol 2009;27:996–7.
   PubMed Web of Science ®Google Scholar
• Matzinger O, Heimsoth I, Poortmans P, Collette L, Struikmans H, Van Den Bogaert W, . Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol 2010;49:24–34.
   PubMed Web of Science ®Google Scholar
• MacDonald SM, Abi-Raad RF, Alm El-Din MA, Niemierko A, Kobayashi W, McGrath JJ, . Taghian chest wall radiotherapy: Middle ground for treatment of patients with one to three positive lymph nodes after mastectomy. Int J Radiat Oncol Biol Phys 2009;75:1297–303.
   PubMed Web of Science ®Google Scholar
• Livi L, Paiar F, Simontacchi G, Barca R, Detti B, Fondelli S, . Loco-regional failure pattern after lumpectomy and breast irradiation in 4,185 patients with T1 and T2 breast cancer. Implications for nodal irradiation. Acta Oncol 2006;45:564–70.
   PubMed Web of Science ®Google Scholar
• Kunkler IH, Canney P, van Tienhoven G, Russell NS. Elucidating the role of chest wall irradiation in ‘Intermediate-risk’ breast cancer: The MRC/EORTC SUPREMO trial. Clin Oncol 2008;20:31–4.
   Web of Science ®Google Scholar